Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Michael E. Ray"'
Autor:
William C. Jackson, MD, Felix Y. Feng, MD, Stephanie Daignault, PhD, Maha Hussain, MD, David Smith, MD, Kathleen Cooney, MD, Kenneth Pienta, MD, Shruti Jolly, MD, Brent Hollenbeck, MD, Karin B. Olson, PA-C, Howard M. Sandler, MD, Michael E. Ray, MD, PhD, Daniel A. Hamstra, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 1, Pp 59-66 (2016)
Purpose/Objective(s): We sought to assess the utility of docetaxel administered concurrently with salvage radiation therapy (SRT) following postprostatectomy biochemical failure (BF). Methods and materials: Men with postprostatectomy BF were accrued
Externí odkaz:
https://doaj.org/article/caf9011c751647a7ac6e69c0815d120f
Supplementary Data from Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature
Autor:
Daniel A. Hamstra, Michael E. Ray, Sonja Markwart, Yash R. Somnay, Aaron C. Spalding, James D. Murphy
Supplementary Data from Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d985c4687ec84f3dc5aae94df1452d5
https://doi.org/10.1158/1078-0432.22440364
https://doi.org/10.1158/1078-0432.22440364
Autor:
Jason A. Efstathiou, Per H. Halvorsen, Colleen A. Lawton, Bridget F. Koontz, Søren M. Bentzen, Caroline Patton, Michael E. Ray, Scott C. Morgan, Daniel W. Lin, D. Andrew Loblaw, Karen E. Hoffman, Michael Chang, Patrick Greany, Mark K. Buyyounouski, DA Barocas, C. Marc Leyrer, Howard M. Sandler
Publikováno v:
The Journal of urology. 201(3)
Purpose The aim of this guideline is to present recommendations regarding moderately hypofractionated (240-340 cGy per fraction) and ultrahypofractionated (500 cGy or more per fraction) radiation therapy for localized prostate cancer. Methods and Mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd2ea99ee5445482ecc1c9e0ec4d304
https://pubmed.ncbi.nlm.nih.gov/30759696
https://pubmed.ncbi.nlm.nih.gov/30759696
Autor:
Michael E. Ray, David Smith, Shruti Jolly, Stephanie Daignault, William C. Jackson, Daniel A. Hamstra, Howard M. Sandler, Felix Y. Feng, Kathleen A. Cooney, Kenneth J. Pienta, Brent K. Hollenbeck, Maha Hussain, Karin B. Olson
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 1, Pp 59-66 (2016)
Advances in Radiation Oncology
Advances in Radiation Oncology
Purpose/Objective(s) We sought to assess the utility of docetaxel administered concurrently with salvage radiation therapy (SRT) following postprostatectomy biochemical failure (BF). Methods and materials Men with postprostatectomy BF were accrued on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe341ad9f63bab535bc6acfd4ceb46ff
http://www.sciencedirect.com/science/article/pii/S2452109415000032
http://www.sciencedirect.com/science/article/pii/S2452109415000032
Autor:
Daniel A. Barocas, Karen E. Hoffman, Scott C. Morgan, Bridget F. Koontz, Jason A. Efstathiou, Per H. Halvorsen, Michael Chang, Colleen A. Lawton, Søren M. Bentzen, Caroline Patton, D. Andrew Loblaw, Daniel W. Lin, Michael E. Ray, Patrick Greany, Mark K. Buyyounouski, Howard M. Sandler, C. Marc Leyrer
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
The aim of this guideline is to present recommendations regarding moderately hypofractionated (240-340 cGy per fraction) and ultrahypofractionated (500 cGy or more per fraction) radiation therapy for localized prostate cancer.The American Society for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91278cb6de0bd492e20aba002bfe30d9
https://pubmed.ncbi.nlm.nih.gov/30307776
https://pubmed.ncbi.nlm.nih.gov/30307776
Autor:
James D. Murphy, Aaron C. Spalding, Michael E. Ray, Yash R. Somnay, Daniel A. Hamstra, Sonja Markwart
Publikováno v:
Clinical Cancer Research. 15:589-596
Purpose: The PI3K/Akt/mTOR prosurvival pathway is frequently up-regulated in soft tissue sarcoma. Mammalian target of rapamycin (mTOR) inhibitors, such as rapamycin, have recently shown clinical benefit in soft tissue sarcoma, and mTOR inhibition has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::528c187bf5306a76d152262982268231
https://doi.org/10.1158/1078-0432.ccr-08-1019
https://doi.org/10.1158/1078-0432.ccr-08-1019
Autor:
Evan T. Keller, Arul M. Chinnaiyan, Kathleen M. Woods Ignatoski, Sonja Markwart, Adaikkalam Vellaichamy, Kam C. Yeung, Michael E. Ray, Navdeep K. Grewal
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 72:153-160
Purpose External beam radiotherapy (RT) is often used in an attempt to cure localized prostate cancer (PCa), but it is only palliative against disseminated disease. Raf kinase inhibitory protein (RKIP) is a metastasis suppressor whose expression is r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07fa1af59710148942a5d2fb48f4924b
https://doi.org/10.1016/j.ijrobp.2008.04.072
https://doi.org/10.1016/j.ijrobp.2008.04.072
Autor:
Charlie C. Pan, Daniel E. Soto, Michael E. Ray, R. Roberts, Scott Glaser, Matthew J. Schipper, Patrick W. McLaughlin, Howard M. Sandler
Publikováno v:
Urology. 71:313-317
Objectives The Radiation Therapy Oncology Group 9413 trial has shown an improvement in progression-free survival (PFS) with external beam radiotherapy that included the pelvic nodes. In clinical practice, two pelvic field size designs are in use. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b63f5a7a19309ee1aa6c6f0105bd062b
https://doi.org/10.1016/j.urology.2007.08.037
https://doi.org/10.1016/j.urology.2007.08.037
Autor:
James D. Murphy, Cornelius J. McGinn, Kent A. Griffith, Vernon K. Sondak, David R. Lucas, Laurence H. Baker, Michael E. Ray, Mary Feng
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 69:103-110
To determine the long-term outcomes after multimodality treatment of retroperitoneal, pelvic, and deep truncal sarcomas and to identify the factors associated with local control (LC), distant metastasis (DM), and overall survival (OS).A total of 85 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91022a3b48b74ca0e68b4b5ba8d127cf
https://doi.org/10.1016/j.ijrobp.2007.02.041
https://doi.org/10.1016/j.ijrobp.2007.02.041
Autor:
Edgar Ben-Josef, James D. Murphy, Saroja Adusumilli, Michael E. Ray, Kent A. Griffith, Mark M. Zalupski, Theodore S. Lawrence
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 68:801-808
Purpose: Full-dose gemcitabine and concurrent radiotherapy is a promising treatment approach in unresectable pancreatic cancer. This study was conducted to assess the pattern of failure and toxicity associated with the use of conformal treatment volu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d85d154aa5c19e1b6de4c6e783c2be1
https://doi.org/10.1016/j.ijrobp.2006.12.053
https://doi.org/10.1016/j.ijrobp.2006.12.053